Balaxi Pharmaceuticals Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: BALAXI Small Cap ISIN: INE618N01022

As on 12 February 2025 at 02:49 IST

₹65.11

-2.89

(-4.25%)

Sell Buy

Over 1 Month

-3.70%

Over 6 Months

-41.98%

Over 1 Year

-41.86%

Over 3 Years

-26.83%

Balaxi Pharmaceuticals Ltd Summary

Close ₹ 65.11

Open ₹ 66.35

High ₹ 66.35

Low ₹ 64.20

Volume 24,153

Net Turnover (in ₹ Cr) ₹ 0.15

52Wk High ₹ 151.45

52Wk Low ₹ 62.78

52Wk High / Low

62.78

151.45

Balaxi Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 359.46

EPS (TTM) 0.53

Book Value (BV) 23.06

Div. Yield -

P/E (TTM) 122.85

Price/Book Value 2.82

Delivery % 52.37 %

Face Value 2

Key Ratios

PE Ratio 148.04

PB Ratio 4.59

EV to Sales 38.09

PEG Ratio -1.87

ROA 2.66

ROE 3.42

Debt-Equity 0.13

Net Profit Margin 5.20

Operating Profit Margin 11.04

Balaxi Pharmaceuticals Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	241.93	339.07	284.36	233.56	46.23
Total Expenses	201.62	282.15	229.84	189.23	37.43
Profit Before Tax	2.02	56.92	54.52	44.33	8.79
Profit After Tax	-2.39	45.96	47.66	38.14	6.10
Operating Profit after Depreciation	41.99	57.42	54.66	44.34	8.79

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	40.88	41.41	28.76	2.45	0.19
Total Non Current Assets	48.17	46.16	35.47	5.91	1.11
Total Current Assets	210.17	193.51	141	93.77	34.86
TOTAL ASSETS	258.34	239.67	176.47	99.68	35.97
Total Shareholder's Fund	201.36	182.88	113.16	64.98	27.75

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	4.87	6.08	34.14	-	-14.04
Net Cash used in Investing Activities	-1.05	-10.57	-28.45	-5.97	-0.18
Net Cash used in Financing Activities	30.25	25.51	-0.16	3.65	18.10

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	72.59	114.74	104.04	88.68	46.23
Total Expenses	67.01	92.29	84.34	68.08	37.04
Profit Before Tax	5.58	22.45	19.70	20.60	9.19
Profit After Tax	3.65	16.22	14.67	15.13	6.50
Operating Profit after Depreciation	7.12	22.91	19.76	20.61	9.19

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	7.10	7.89	2.20	0.69	0.19
Total Non Current Assets	31.46	30.70	27.84	20.25	1.21
Total Current Assets	122.90	99.02	54.08	48.67	36.70
TOTAL ASSETS	154.36	129.72	81.92	68.92	37.91
Total Shareholder's Fund	121.55	92.11	57.91	43.25	28.11

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-1.83	-7.07	8.89	13.46	-14.37
Net Cash used in Investing Activities	0.47	-2.29	-6.87	-20.03	-0.28
Net Cash used in Financing Activities	27.55	26.39	-1.64	3.49	18.10

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	73.29	77.38	65.62	59.83	60.79
Total Expenses	69.30	66.80	55.54	46.37	47.13
Profit Before Tax	6.07	5.56	7.37	11.48	14.28
Profit After Tax	5.36	4.59	6.48	10.93	13.59
Operating Profit after Depreciation	7.93	6.47	8.23	11.67	13.53

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	11.16	21.16	19.03	15.90	12.70
Total Expenses	11.06	19.67	17.51	15.70	12.42
Profit Before Tax	2.34	2.21	1.90	-0.27	0.77
Profit After Tax	1.74	1.66	1.38	-0.58	0.49
Operating Profit after Depreciation	3.02	2.78	2.37	0.36	1.31

Balaxi Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 66.18

S2 64.36

S3 62.05

Pivot 68.49

R1 70.31

R2 72.62

R3 74.44

Moving Average

20 SMA 70.26

50 SMA 74.75

100 SMA 83.28

200 SMA 99.92

Balaxi Pharmaceuticals Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

Balaxi Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Balaxi Pharmaceuticals Ltd	₹65.11	₹359.46
Sun Pharmaceuticals Industries Ltd	₹1,699.75	₹4,07,826.96
Divis Laboratories Ltd	₹5,949.15	₹1,57,931.24
Cipla Ltd	₹1,452.70	₹1,17,322.09
Torrent Pharmaceuticals Ltd	₹3,104.95	₹1,05,080.90
Mankind Pharma Ltd	₹2,451.35	₹1,01,134.59

Balaxi Pharmaceuticals Ltd News

Balaxi Pharmaceuticals to convene board meeting

On 10 February 2025

03 Feb 2025, 10:51 am

Balaxi Pharmaceuticals announces board meeting date

On 5 November 2024

30 Oct 2024, 04:58 pm

Balaxi Pharmaceuticals to conduct AGM

On 23 August 2024

01 Aug 2024, 12:52 pm

Balaxi Pharmaceuticals to convene board meeting

On 2 August 2024

26 Jul 2024, 10:45 am

Balaxi Pharma soars after expanding market presence in Angola & Latin America

Balaxi Pharmaceuticals jumped 5.19% to Rs 126.50 after the company announced strategic hospital partnerships in Angola and securing of tender business in Latin America.

25 Jun 2024, 12:14 pm

Balaxi Pharmaceuticals Ltd Stock Analysis

Annual revenue for Balaxi Pharmaceuticals Ltd decreased by 36.73% to ₹72.59 crore in FY 2024 from ₹114.74 crore in FY 2023.
Annual Net Profit for Balaxi Pharmaceuticals Ltd decreased by 77.50% to ₹3.65 crore in FY 2024 from ₹16.22 crore in FY 2023.
Promoter Shareholding in Balaxi Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 65.99% in September 2024 to 65.99% in December 2024.
Balaxi Pharmaceuticals Ltd delivered a 1-year return of -41.86% compared to the Nifty 50, which provided a return of 6.73% as of the last trading session.
Balaxi Pharmaceuticals Ltd share price moved down by 4.25% from its previous close of INR ₹68. The latest Balaxi Pharmaceuticals Ltd share price is INR ₹65.11.
Balaxi Pharmaceuticals Ltd share price today has been at a low of 64.20 and a high of 66.35. Over the past 52 weeks, the Balaxi Pharmaceuticals Ltd share price has seen a low of 62.78 and a high of 151.45.